The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-03-06
DOI
10.3389/fendo.2020.00103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity
- (2019) Anna C Simcocks et al. Endocrine Connections
- Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer
- (2019) Andrea Tomko et al. Frontiers in Pharmacology
- LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling
- (2018) Inmaculada Ruz-Maldonado et al. DIABETES OBESITY & METABOLISM
- Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets
- (2018) Isabel González-Mariscal et al. DIABETOLOGIA
- Insulin resistance causes inflammation in adipose tissue
- (2018) Mitsugu Shimobayashi et al. JOURNAL OF CLINICAL INVESTIGATION
- Adipose tissue derived-factors impaired pancreatic β-cell function in diabetes
- (2018) Sandra A. Rebuffat et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice
- (2017) Silvana Y. Romero-Zerbo et al. Scientific Reports
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
- (2016) Aine M. McKillop et al. DIABETOLOGIA
- Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
- (2016) Regina M. Krohn et al. Journal of Inflammation-London
- Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis
- (2016) Alexander I. Bondarenko et al. THROMBOSIS AND HAEMOSTASIS
- The cannabinoid CB1receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice
- (2015) Francisco J. Bermudez-Silva et al. Disease Models & Mechanisms
- Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis
- (2015) Cristoforo Silvestri et al. JOURNAL OF HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- G protein coupled receptor 18: A potential role for endocannabinoid signaling in metabolic dysfunction
- (2015) Gayathri Rajaraman et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
- (2014) Lili Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
- (2013) A M McKillop et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cytokine profiling of young overweight and obese female African American adults with prediabetes
- (2013) Rudolf Lucas et al. CYTOKINE
- Resident Macrophages Mediate Islet Amyloid Polypeptide–Induced Islet IL-1β Production and β-Cell Dysfunction
- (2013) Clara Y. Westwell-Roper et al. DIABETES
- Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
- (2013) Tony Jourdan et al. NATURE MEDICINE
- Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain–gut axis
- (2012) Nina L. Cluny et al. BRAIN BEHAVIOR AND IMMUNITY
- A potential role for GPR55 in gastrointestinal functions
- (2012) Rudolf Schicho et al. CURRENT OPINION IN PHARMACOLOGY
- Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice
- (2012) Kun Li et al. PANCREAS
- Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
- (2012) Jonathan A. Farrimond et al. PSYCHOPHARMACOLOGY
- Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
- (2011) Partha Mukhopadhyay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
- (2011) George W. Booz FREE RADICAL BIOLOGY AND MEDICINE
- Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice
- (2011) Andrew M. Miller et al. HEPATOLOGY
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
- (2010) T. Jourdan et al. DIABETES
- From the metabolic syndrome to NAFLD or vice versa?
- (2010) Ester Vanni et al. DIGESTIVE AND LIVER DISEASE
- Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors
- (2010) Bogna Ignatowska-Jankowska et al. NEUROSCIENCE LETTERS
- The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
- (2010) A. J. Sanyal et al. ONCOLOGIST
- The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
- (2010) F.J. Bermudez-Silva et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Dexamethasone treatment in vivo counteracts the functional pancreatic islet alterations caused by malnourishment in rats
- (2008) Vanessa A.G. Giozzet et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started